BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loo KY, Letchumanan V, Ser HL, Teoh SL, Law JW, Tan LT, Ab Mutalib NS, Chan KG, Lee LH. COVID-19: Insights into Potential Vaccines. Microorganisms 2021;9:605. [PMID: 33804162 DOI: 10.3390/microorganisms9030605] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Tan TL, Salleh SA, Che Man Z, Tan MHP, Kader R, Jarmin R. BNT162b2 COVID-19 Vaccination and Its Effect on Blood Pressure. Medicina (Kaunas) 2022;58. [PMID: 36556993 DOI: 10.3390/medicina58121789] [Reference Citation Analysis]
2 Danilov AN, Eremin VI, Filippova NA, Denisova EG. Vaccines against new coronavirus infection in Russia and the world. Epidemiology and Infectious Diseases 2022;26:283-293. [DOI: 10.17816/eid106032] [Reference Citation Analysis]
3 Sahoo SS, Kaur N, Kaur A, Garg S. Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona virus vaccine: ultrasound findings and clinical implications. Ther Adv Vaccines Immunother 2022;10:25151355221124018. [PMID: 36133302 DOI: 10.1177/25151355221124018] [Reference Citation Analysis]
4 Mendiratta K, Solanki S, Rathi B, Bhandari S, Bellamkondi A, Parihar BS, Singh A, Parakh P. Chest HRCT Assessment of COVID-19 Patients in Vaccinated versus Nonvaccinated Patients: A Comparative Study in a Tertiary Care Hospital. Indian J Radiol Imaging. [DOI: 10.1055/s-0042-1750157] [Reference Citation Analysis]
5 Alkhafaji DM, Al Argan RJ, Albahrani S, Alwaheed AJ, Alqatari SG, Al Elq AH, Albaker W, Alwazzeh M, Alsulaiman AS, Alsulaiman RS, Almadan HM, Alhammad AA, Almajid AN, Hakami FH, Alanazi WK. The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease. IDR 2022;Volume 15:3477-89. [DOI: 10.2147/idr.s365179] [Reference Citation Analysis]
6 Mir I, Aamir S, Shah SRH, Shahid M, Amin I, Afzal S, Nawaz A, Khan MU, Idrees M. Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic. PHRP 2022;13:84-100. [DOI: 10.24171/j.phrp.2022.0024] [Reference Citation Analysis]
7 Belete TM. The Immune Response, Safety, and Efficacy of Emergency Use Authorization-Granted COVID-19 Vaccines: A Review. TOMICROJ 2022;16:e187428582201240. [DOI: 10.2174/18742858-v16-e2201240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jung BK, An YH, Jang JJ, Jeon JH, Jang SH, Jang H. The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate. PLoS One 2022;17:e0263684. [PMID: 35134091 DOI: 10.1371/journal.pone.0263684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Stoma I, Korsak K, Voropaev E, Osipkina O, Kovalev A. Comparative study of immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in Belarus.. [DOI: 10.1101/2022.02.05.22270499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Choudhury PR, Saha T, Goel S, Shah JM, Ganjewala D. Cross-species virus transmission and its pandemic potential. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00701-7] [Reference Citation Analysis]
11 Schiano di Cola F, Caratozzolo S, Liberini P, Padovani A, Rao R. CGRP-monoclonal antibodies and SARS-CoV-2 vaccination. J Neurol 2022. [PMID: 34999961 DOI: 10.1007/s00415-021-10946-3] [Reference Citation Analysis]
12 Subedi P, Yadav GK, Paudel B, Regmi A, Pyakurel P. Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study. PLoS One 2021;16:e0260638. [PMID: 34932553 DOI: 10.1371/journal.pone.0260638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy PH, De Feo V, Dewanjee S. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Biomedicines 2021;9:1740. [PMID: 34829969 DOI: 10.3390/biomedicines9111740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
14 Pundir H, Joshi T, Pant M, Bhat S, Pandey J, Chandra S, Tamta S. Identification of SARS-CoV-2 RNA dependent RNA polymerase inhibitors using pharmacophore modelling, molecular docking and molecular dynamics simulation approaches. J Biomol Struct Dyn 2022;40:13366-77. [PMID: 34637693 DOI: 10.1080/07391102.2021.1987329] [Reference Citation Analysis]
15 Zawahrah HJ, Saca-Hazboun H, Melhem SS, Adwan R, Sabateen A, Abu-Rmeileh NME. Acceptance of COVID-19 vaccines in Palestine: a cross-sectional online study. BMJ Open 2021;11:e053681. [PMID: 34620671 DOI: 10.1136/bmjopen-2021-053681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Thye AY, Law JW, Pusparajah P, Letchumanan V, Chan KG, Lee LH. Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis. Biomedicines 2021;9:1303. [PMID: 34680420 DOI: 10.3390/biomedicines9101303] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 21.0] [Reference Citation Analysis]
17 Shahjaman M, Rezanur Rahman M, Rabiul Auwul M. A network-based systems biology approach for identification of shared Gene signatures between male and female in COVID-19 datasets. Inform Med Unlocked 2021;25:100702. [PMID: 34423108 DOI: 10.1016/j.imu.2021.100702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci 2021;22:8663. [PMID: 34445368 DOI: 10.3390/ijms22168663] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
19 Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, Shaban D, Al Khames Aga LA, Agha MYR, Traqchi M. Safety of COVID-19 vaccines. J Med Virol 2021. [PMID: 34270094 DOI: 10.1002/jmv.27214] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
20 Migliore A, Gigliucci G, Di Marzo R, Russo D, Mammucari M. Intradermal Vaccination: A Potential Tool in the Battle Against the COVID-19 Pandemic? Risk Manag Healthc Policy 2021;14:2079-87. [PMID: 34045909 DOI: 10.2147/RMHP.S309707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]